Other
Monoclonal
0
Pipeline Programs↗
10
Active Trials↗
14
Companies Involved↗
Monoclonal is an early-stage landscape with 0 programs across 14 companies. The most active players are Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Brii Biosciences Limited, Genor Biopharma Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
75
clinical trials
Completed42 · 56%
Unknown status17 · 23%
Recruiting5 · 7%
Active, not recruiting3 · 4%
Terminated3 · 4%
Withdrawn2 · 3%
Other3 · 4%
Clinical Trials
Trial Activity
75 trials
Safety of RSV Preventive Monoclonal Antibody
Recruiting·—·Phase 4·NCT07158814·524 enrolled
First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
Active, not recruiting·—·Phase 1·NCT05737628·17 enrolled
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Active, not recruiting·—·N/A·NCT02293954·20 enrolled
A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody
Not yet recruiting·LLanzhou Institute of Biological Products Co., Ltd·Phase 2·NCT07445815·200 enrolled
Dose-finding Study of LFB-R593, A Monoclonal Anti-RhD Antibody, in Healthy RhD Negative Volunteers
Completed·LLaboratoire français de Fractionnement et de Biotechnologies·Phase 2·NCT00952575·78 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)